HEADER HORMONE RECEPTOR 14-SEP-17 6B0F TITLE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH LSZ102 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 301-553; COMPND 5 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP A MEMBER 1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR RECEPTOR, HORMONE RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR C.A.KIRBY,J.BAIRD REVDAT 5 03-APR-24 6B0F 1 REMARK REVDAT 4 13-MAR-24 6B0F 1 REMARK REVDAT 3 25-DEC-19 6B0F 1 COMPND HETNAM HETSYN REVDAT 2 25-APR-18 6B0F 1 JRNL REVDAT 1 04-APR-18 6B0F 0 JRNL AUTH G.S.TRIA,T.ABRAMS,J.BAIRD,H.E.BURKS,B.FIRESTONE,L.A.GAITHER, JRNL AUTH 2 L.G.HAMANN,G.HE,C.A.KIRBY,S.KIM,F.LOMBARDO,K.J.MACCHI, JRNL AUTH 3 D.P.MCDONNELL,Y.MISHINA,J.D.NORRIS,J.NUNEZ,C.SPRINGER,Y.SUN, JRNL AUTH 4 N.M.THOMSEN,C.WANG,J.WANG,B.YU,C.L.TIONG-YIP,S.PEUKERT JRNL TITL DISCOVERY OF LSZ102, A POTENT, ORALLY BIOAVAILABLE SELECTIVE JRNL TITL 2 ESTROGEN RECEPTOR DEGRADER (SERD) FOR THE TREATMENT OF JRNL TITL 3 ESTROGEN RECEPTOR POSITIVE BREAST CANCER. JRNL REF J. MED. CHEM. V. 61 2837 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 29562737 JRNL DOI 10.1021/ACS.JMEDCHEM.7B01682 REMARK 2 REMARK 2 RESOLUTION. 2.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.84 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 11202 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.231 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 538 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.86 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.41 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2672 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2214 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2529 REMARK 3 BIN R VALUE (WORKING SET) : 0.2166 REMARK 3 BIN FREE R VALUE : 0.3068 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.35 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3098 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 17 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 68.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 20.06250 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : -3.04010 REMARK 3 B13 (A**2) : -17.02240 REMARK 3 B23 (A**2) : -0.05510 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.420 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.445 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.875 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.810 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3233 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4360 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1156 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 73 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 446 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3233 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 407 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3785 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.37 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.60 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6B0F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1000230098. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-FEB-14 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11212 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.860 REMARK 200 RESOLUTION RANGE LOW (A) : 48.210 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.58300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER 2.11.7 REMARK 200 STARTING MODEL: 1MTYS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL (PH 8.5), 22% PEG 3350, REMARK 280 0.20 M MAGNESIUM CHLORIDE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 52.91000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 52.91000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 26.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17620 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 300 REMARK 465 SER A 301 REMARK 465 LYS A 302 REMARK 465 LYS A 303 REMARK 465 ASN A 304 REMARK 465 SER A 305 REMARK 465 LEU A 306 REMARK 465 ALA A 307 REMARK 465 LEU A 308 REMARK 465 GLU A 330 REMARK 465 TYR A 331 REMARK 465 ASP A 332 REMARK 465 PRO A 333 REMARK 465 THR A 334 REMARK 465 ARG A 335 REMARK 465 PRO A 336 REMARK 465 PHE A 337 REMARK 465 ARG A 412 REMARK 465 ASN A 413 REMARK 465 GLN A 414 REMARK 465 GLY A 415 REMARK 465 LYS A 416 REMARK 465 SER A 417 REMARK 465 VAL A 458 REMARK 465 TYR A 459 REMARK 465 THR A 460 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 GLU A 470 REMARK 465 GLU A 471 REMARK 465 LYS A 472 REMARK 465 ASP A 473 REMARK 465 SER A 527 REMARK 465 MET A 528 REMARK 465 ASP A 545 REMARK 465 ALA A 546 REMARK 465 HIS A 547 REMARK 465 ARG A 548 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 GLY B 300 REMARK 465 SER B 301 REMARK 465 LYS B 302 REMARK 465 LYS B 303 REMARK 465 ASN B 304 REMARK 465 SER B 305 REMARK 465 LEU B 306 REMARK 465 ALA B 307 REMARK 465 GLU B 330 REMARK 465 TYR B 331 REMARK 465 ASP B 332 REMARK 465 PRO B 333 REMARK 465 THR B 334 REMARK 465 ARG B 335 REMARK 465 PRO B 336 REMARK 465 PHE B 337 REMARK 465 SER B 338 REMARK 465 THR B 371 REMARK 465 LEU B 372 REMARK 465 HIS B 373 REMARK 465 ARG B 412 REMARK 465 ASN B 413 REMARK 465 GLN B 414 REMARK 465 GLY B 415 REMARK 465 LYS B 416 REMARK 465 SER B 417 REMARK 465 VAL B 418 REMARK 465 GLU B 419 REMARK 465 GLY B 420 REMARK 465 VAL B 458 REMARK 465 TYR B 459 REMARK 465 THR B 460 REMARK 465 PHE B 461 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 SER B 464 REMARK 465 THR B 465 REMARK 465 LEU B 466 REMARK 465 LYS B 467 REMARK 465 SER B 468 REMARK 465 LEU B 469 REMARK 465 TYR B 526 REMARK 465 SER B 527 REMARK 465 MET B 528 REMARK 465 LYS B 529 REMARK 465 SER B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 LEU B 536 REMARK 465 TYR B 537 REMARK 465 ASP B 538 REMARK 465 LEU B 539 REMARK 465 LEU B 540 REMARK 465 LEU B 541 REMARK 465 GLU B 542 REMARK 465 MET B 543 REMARK 465 LEU B 544 REMARK 465 ASP B 545 REMARK 465 ALA B 546 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 534 127.30 -39.13 REMARK 500 PRO B 365 105.42 -36.98 REMARK 500 ASP B 369 40.18 -88.70 REMARK 500 SER B 395 7.93 -68.48 REMARK 500 HIS B 398 78.99 -118.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C6V A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C6V B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 602 DBREF 6B0F A 301 553 UNP P03372 ESR1_HUMAN 301 553 DBREF 6B0F B 301 553 UNP P03372 ESR1_HUMAN 301 553 SEQADV 6B0F GLY A 300 UNP P03372 EXPRESSION TAG SEQADV 6B0F SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 6B0F SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 6B0F SER A 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQADV 6B0F GLY B 300 UNP P03372 EXPRESSION TAG SEQADV 6B0F SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 6B0F SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 6B0F SER B 530 UNP P03372 CYS 530 ENGINEERED MUTATION SEQRES 1 A 254 GLY SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA SEQRES 2 A 254 ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO SEQRES 3 A 254 ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER SEQRES 4 A 254 GLU ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP SEQRES 5 A 254 ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL SEQRES 6 A 254 PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS SEQRES 7 A 254 LEU LEU GLU SER ALA TRP LEU GLU ILE LEU MET ILE GLY SEQRES 8 A 254 LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU SEQRES 9 A 254 PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SEQRES 10 A 254 SER VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU SEQRES 11 A 254 ALA THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY SEQRES 12 A 254 GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SEQRES 13 A 254 SER GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER SEQRES 14 A 254 LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS SEQRES 15 A 254 ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY SEQRES 16 A 254 LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU SEQRES 17 A 254 LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS SEQRES 18 A 254 GLY MET GLU HIS LEU TYR SER MET LYS SER LYS ASN VAL SEQRES 19 A 254 VAL PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA SEQRES 20 A 254 HIS ARG LEU HIS ALA PRO THR SEQRES 1 B 254 GLY SER LYS LYS ASN SER LEU ALA LEU SER LEU THR ALA SEQRES 2 B 254 ASP GLN MET VAL SER ALA LEU LEU ASP ALA GLU PRO PRO SEQRES 3 B 254 ILE LEU TYR SER GLU TYR ASP PRO THR ARG PRO PHE SER SEQRES 4 B 254 GLU ALA SER MET MET GLY LEU LEU THR ASN LEU ALA ASP SEQRES 5 B 254 ARG GLU LEU VAL HIS MET ILE ASN TRP ALA LYS ARG VAL SEQRES 6 B 254 PRO GLY PHE VAL ASP LEU THR LEU HIS ASP GLN VAL HIS SEQRES 7 B 254 LEU LEU GLU SER ALA TRP LEU GLU ILE LEU MET ILE GLY SEQRES 8 B 254 LEU VAL TRP ARG SER MET GLU HIS PRO GLY LYS LEU LEU SEQRES 9 B 254 PHE ALA PRO ASN LEU LEU LEU ASP ARG ASN GLN GLY LYS SEQRES 10 B 254 SER VAL GLU GLY MET VAL GLU ILE PHE ASP MET LEU LEU SEQRES 11 B 254 ALA THR SER SER ARG PHE ARG MET MET ASN LEU GLN GLY SEQRES 12 B 254 GLU GLU PHE VAL CYS LEU LYS SER ILE ILE LEU LEU ASN SEQRES 13 B 254 SER GLY VAL TYR THR PHE LEU SER SER THR LEU LYS SER SEQRES 14 B 254 LEU GLU GLU LYS ASP HIS ILE HIS ARG VAL LEU ASP LYS SEQRES 15 B 254 ILE THR ASP THR LEU ILE HIS LEU MET ALA LYS ALA GLY SEQRES 16 B 254 LEU THR LEU GLN GLN GLN HIS GLN ARG LEU ALA GLN LEU SEQRES 17 B 254 LEU LEU ILE LEU SER HIS ILE ARG HIS MET SER ASN LYS SEQRES 18 B 254 GLY MET GLU HIS LEU TYR SER MET LYS SER LYS ASN VAL SEQRES 19 B 254 VAL PRO LEU TYR ASP LEU LEU LEU GLU MET LEU ASP ALA SEQRES 20 B 254 HIS ARG LEU HIS ALA PRO THR HET C6V A 601 33 HET GOL A 602 6 HET GOL A 603 6 HET C6V B 601 33 HET GOL B 602 6 HETNAM C6V LSZ102 HETNAM GOL GLYCEROL HETSYN C6V (2E)-3-[4-({2-[2-(1,1-DIFLUOROETHYL)-4-FLUOROPHENYL]-6- HETSYN 2 C6V HYDROXY-1-BENZOTHIOPHEN-3-YL}OXY)PHENYL]PROP-2-ENOIC HETSYN 3 C6V ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 C6V 2(C25 H17 F3 O4 S) FORMUL 4 GOL 3(C3 H8 O3) FORMUL 8 HOH *17(H2 O) HELIX 1 AA1 THR A 311 GLU A 323 1 13 HELIX 2 AA2 GLU A 339 VAL A 364 1 26 HELIX 3 AA3 THR A 371 SER A 381 1 11 HELIX 4 AA4 ALA A 382 SER A 395 1 14 HELIX 5 AA5 MET A 396 HIS A 398 5 3 HELIX 6 AA6 GLY A 420 MET A 438 1 19 HELIX 7 AA7 GLN A 441 SER A 456 1 16 HELIX 8 AA8 ILE A 475 ALA A 493 1 19 HELIX 9 AA9 THR A 496 TYR A 526 1 31 HELIX 10 AB1 PRO A 535 LEU A 544 1 10 HELIX 11 AB2 THR B 311 GLU B 323 1 13 HELIX 12 AB3 ALA B 340 ARG B 363 1 24 HELIX 13 AB4 GLN B 375 SER B 395 1 21 HELIX 14 AB5 MET B 396 HIS B 398 5 3 HELIX 15 AB6 VAL B 422 MET B 438 1 17 HELIX 16 AB7 GLN B 441 SER B 456 1 16 HELIX 17 AB8 LYS B 472 GLY B 494 1 23 HELIX 18 AB9 THR B 496 LEU B 525 1 30 SHEET 1 AA1 2 LEU A 402 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 LEU A 410 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LEU B 402 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 LEU B 410 -1 O LEU B 410 N LEU B 402 SITE 1 AC1 18 LEU A 346 THR A 347 LEU A 349 GLU A 353 SITE 2 AC1 18 LEU A 387 ARG A 394 PHE A 404 MET A 421 SITE 3 AC1 18 ILE A 424 PHE A 425 LEU A 428 GLY A 521 SITE 4 AC1 18 HIS A 524 LEU A 525 TYR A 526 LYS A 531 SITE 5 AC1 18 ASN A 532 VAL A 533 SITE 1 AC2 3 GLU A 323 PRO A 325 ARG A 394 SITE 1 AC3 4 GLN A 441 GLU A 444 ALA A 493 ARG A 503 SITE 1 AC4 12 MET B 343 LEU B 346 THR B 347 GLU B 353 SITE 2 AC4 12 LEU B 387 ARG B 394 PHE B 404 ILE B 424 SITE 3 AC4 12 PHE B 425 LEU B 428 GLY B 521 HIS B 524 SITE 1 AC5 8 LEU A 327 ARG A 352 HIS A 356 LEU B 327 SITE 2 AC5 8 TYR B 328 ARG B 352 HIS B 356 HOH B 702 CRYST1 105.820 52.100 97.020 90.00 114.33 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009450 0.000000 0.004273 0.00000 SCALE2 0.000000 0.019194 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011312 0.00000